JBM's (Healthcare) (HKG:2161) subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson Pharma (HKG:2633), for HK$46.2 million, a Tuesday Hong Kong bourse filing said.
Li Chung Shing Tong is a Chinese medicine producer and distributor with HK$132.5 million in assets as of Oct. 31.
Upon completion of the deal, Po Chai Herbal will still own 43.9% of the total issued shares of Li Chung Shing Tong, and the target company will remain a subsidiary of JBM.
JBM plans to use the net proceeds of HK$46 million for the general working capital of the group.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。